Vietnam's major pharma firm DHG to pay 60% cash dividend

Hau Giang Pharmaceutical JSC (DHG Pharma), a leading pharma company in Vietnam, said it will pay a 60% cash dividend, equivalent to VND6,000 ($0.23) per share.

The final registration date is May 26, with payment scheduled for June 18.

With nearly 131 million shares outstanding, DHG Pharma, listed on the Ho Chi Minh Stock Exchange (HoSE) as DHG, is expected to allocate approximately VND786 billion ($30.29 million) for dividend payouts.

Its largest shareholder, Japan's Taisho Pharmaceutical Co., Ltd., which holds over 51% of the company, is set to receive around VND400 billion ($15.41 million).

Meanwhile, the State Capital Investment Corporation (SCIC), Vietnam’s government investment arm, which owns more than 43% of the shares, will get around VND338 billion ($13.02 million).

Earlier, DHG Pharma paid an interim cash dividend for 2024 at a rate of 40% (VND4,000 or $0.15 per share). The company completed the payment on February 14, 2025, with a total payout of about VND523 billion ($20.15 million).

The 2024 cash dividend at a rate of 100% was approved by the 2025 AGM on April 24.

With a market capitalization of nearly VND13.6 trillion ($524.04 million), DHG Pharma is currently the largest pharmaceutical company listed on Vietnam's stock market.

The company has a history of high cash dividend payouts, consistently maintaining a rate of 35-40%. In 2023, it paid a substantial cash dividend of 75%.

According to its Q1/2025 financial report, DHG Pharma recorded net revenue of nearly VND1.2 trillion ($46.23 million), a 5% decline compared to the same period last year.

However, its gross profit margin improved to 47.4%, from 40.7% in the same period last year.

As a result, DHG Pharma posted a net profit of VND266 billion ($10.25 million), a 20% increase year-on-year, marking the highest profit since Q2/2023.

In 2025, the company aims for a revenue of VND5.21 trillion ($200.76 million) and a pre-tax profit of VND940 billion ($36.21 million), up 7% and 4% respectively from the previous year.

After the first three months, the company achieved 23% of its revenue target and 31% of its pre-tax profit goal for the year.

At the 2025 AGM, the company said it had previously focused on the wholesale channel but is now shifting towards targeting end consumers through marketing activities.

This focus on end customers could be a contributing factor to DHG’s improved profit margin, but it also led to higher selling expenses in Q1.

On the HoSE, DHG closed Tuesday at VND107,400 ($4.14) per share.